Schechter Investment Advisors’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Schechter Investment Advisors’s Portfolio EUCRU Stock Details EUCRU Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$792K	Buy
2022 Q2	$759K	Sell
2022 Q1	$816K	Sell
2021 Q4	$872K	Buy